---
name: StemExpress
slug: stemexpress
site: cro
website_domain: stemexpress.com
summary: StemExpress, now part of CGT Global, supplies biospecimens and cellular starting materials for cell and gene therapy research, including GMP-grade leukopaks, PBMCs, bone marrow, and cord blood for clinical and research applications. Headquartered in Edinburgh, United Kingdom.
tagline: Biospecimens and cellular starting materials for cell and gene therapy research.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: GB
tier2_domain_verified: false
updated_at: 2026-10-12T07:04:56.793Z
services_count: 1
modalities_count: 2
indications_count: 0
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# StemExpress

Biospecimens and cellular starting materials for cell and gene therapy research.

Listed on cro.directory.

## Summary

StemExpress, now part of CGT Global, supplies biospecimens and cellular starting materials for cell and gene therapy research, including GMP-grade leukopaks, PBMCs, bone marrow, and cord blood for clinical and research applications. Headquartered in Edinburgh, United Kingdom.

## At a glance

- HQ country: GB

## Services

- Translational Research

## Modalities

- Cell Therapy
- Gene Therapy

## Locations

- Edinburgh, Edinburgh, United Kingdom

## Long description

StemExpress operates as a biospecimen and cellular starting materials provider serving the cell and gene therapy research and clinical development sectors. The company supplies a range of human blood products and tissues including RUO (research use only) leukopaks, GMP-grade leukopaks engineered for clinical excellence, mobilized peripheral blood products, PBMCs, whole blood, bone marrow, cord blood, and isolated cell populations. StemExpress also offers CellsExpress bulk cell isolation services for custom processing. The company maintains a cryo inventory system for specimen tracking and provides technical support, case studies, and publications to support client research programs. Services include cell processing, isolation, and tissue collection capabilities designed to support preclinical discovery and clinical development of cell and gene therapies.

## Related companies

- [SGVector](/companies/sgvector) (Translational Research, Cell Therapy) — [Compare](/compare/sgvector/stemexpress)
- [AAVATAR Therapeutics](/companies/en-aavatartps) (Translational Research, Gene Therapy) — [Compare](/compare/en-aavatartps/stemexpress)
- [TATAA Biocenter](/companies/tataa-biocenter) (Translational Research, Cell Therapy) — [Compare](/compare/stemexpress/tataa-biocenter)
- [uBriGene](/companies/ubrigene) (Translational Research, Cell Therapy) — [Compare](/compare/stemexpress/ubrigene)
- [Esco Aster](/companies/escoaster) (Translational Research, Cell Therapy) — [Compare](/compare/escoaster/stemexpress)
- [Ubigene Biosciences](/companies/ubigene) (Translational Research, Gene Therapy) — [Compare](/compare/stemexpress/ubigene)
- [Accelevir](/companies/accelevirdx) (Translational Research, Cell Therapy) — [Compare](/compare/accelevirdx/stemexpress)
- [Cellentia, Inc.](/companies/cellentiabio) (Translational Research, Cell Therapy) — [Compare](/compare/cellentiabio/stemexpress)

_Profile last updated: 2026-10-12T07:04:56.793Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.